Anupco


CTC 20%

Water soluble powder

COMPOSITION

Chlortetracycline hydrochloride 200 mg/g

PHARMACOLOGICAL PROPERTIES

Chlortetracycline has a broad spectrum antibacterial activity against a wide range of Gram-positive and Gram-negative bacteria including the majority of strains of E. coli. At the dosages recommended, the antimicrobial activity of chlortetracycline is bacteriostatic.

Of primary importance is plasmind mediated resistance. There is complete cross-resistance with other antibiotics of the tetracycline group.

Chlortetracycline is readily but incompletely absorbed after oral administration. Tissue concentrations are the highest inátheáliver and kidneys, with maximum concentrations found in the liver 2 hours after the administration, and after 1 hour in the kidneys. The largest part is excretedáthrough the urine, but also with the bile.

INDICATIONS

Prevention and treatment of Coliform Septicaemia, Omphalitis, Synovitis, Fowl Cholera, Pullet Disease, Chronic Respiratory Disease (CRD) and other diseases including bacterial infection following Infectious Bronchitis, Newcastle Disease, Coccidiosis, vaccination and other periods of stress. Also for use against early non-specific mortality in chicks.

CONTRA-INDICATIONS

Administration to animals with a previous history of hypersensitivity towards tetracyclines.

DOSAGE AND MODE OF ADMINISTRATION

For oral administration.

Dissolveá100 g CTC 20% perá150 litres drinking water. Continue treatment for 5-7 days.

UNDESIRABLE EFFECTS

Chlortetracycline is well tolerated and has a broad safety margin. Gastrointestinal disturbances may occur at recommended dosages with superinfections of yeasts and non-susceptible bacteria. Allergic reactions in hypersensitised animals only seldom occur.

SPECIAL PRECAUTIONS AND WARNINGS

In farms where tetracycline antibiotics are regularly used, it is advised to control susceptibility of presumable pathogens by means of an antibiogram. Drinking water facilities (tanks, conduit pipes, nipples, etc.) should be cleaned properly after cessation of medication. Facilities completely separate from the normal drinking water provisions are advised.

Since tetracyclines have shown teratogenic potential in laboratory animals (may slow down bone growth of foeti and neonati and cause discolouration of bones and deciduous teeth) oxytetracycline should only be used in pregnant animals when it is therapeutically justified.

PACK SIZE

150 g, 1 kg.

Please be aware that product specifications and availability can differ between countries. For detailed information in this regard, please contact us.

You are viewing the English version of this website enesfr